Brazil approves use of medical marijuana derivative
Share this on

Brazil approves use of medical marijuana derivative

Brazil has approved the use of a marijuana derivative to treat people suffering from severe seizures.

Directors of the country’s Health Surveillance Agency on Wednesday recognized the therapeutic properties of cannabidiol, saying it is now a “controlled” substance and no longer illegal.

It can now be used to treat epilepsy, multiple sclerosis and schizophrenia among other disorders.

Cannabidiol is not produced in Brazil and the agency said it will draw up legislation permitting it to be imported.

Last month, the Federal Medical Council that regulates the medical profession in Brazil authorized neurologists and psychiatrists to prescribe cannabidiol to treat epileptic children and teenagers who do not respond to conventional treatment.